Hepatitis B virus (HBV) surface antigen (HBsAg) inhibition with isis 505358 in chronic hepatitis B (CHB) patients on stable nucleos (t)ide analogue (NA) regimen and in NA-naive CHB patients: phase 2a, randomized, double-blind, placebo-controlled study

Man‐Fung Yuen, Jeong Heo, Jeong Won Jang, Jung‐Hwan Yoon, Young Oh Kweon, Sung-Jae Park, C. Frank Bennett, T. Jesse Kwoh